| Literature DB >> 35508347 |
Hannah M L Young1,2, Thomas Yates2, Paddy C Dempsey2,3,4, Louisa Y Herring5, Joseph Henson5,2, Jack Sargeant5,2, Ffion Curtis6, Harini Sathanapally6, Patrick J Highton6, Michelle Hadjiconstantinou2, Rebecca Pritchard7,8, Selina Lock9, Sally J Singh10,11, Melanie J Davies5,2.
Abstract
INTRODUCTION: The number of people living with multiple long-term conditions (MLTCs) is predicted to rise. Within this population, those also living with frailty are particularly vulnerable to poor outcomes, including decreased function. Increased physical activity, including exercise, has the potential to improve function in those living with both MLTCs and frailty but, to date, the focus has remained on older people and may not reflect outcomes for the growing number of younger people living with MLTCs and frailty. For those with higher burdens of frailty and MLTCs, physical activity may be challenging. Tailoring physical activity in response to symptoms and periods of ill-health, involving family and reducing sedentary behaviour may be important in this population. How the tailoring of interventions has been approached within existing studies is currently unclear. This scoping review aims to map the available evidence regarding these interventions in people living with both frailty and MLTCs. METHODS AND ANALYSIS: We will use a six-stage process: (1) identifying the research questions; (2) identifying relevant studies (via database searches); (3) selecting studies; (4) charting the data; (5) collating and summarising and (6) stakeholder consultation. Studies will be critically appraised using the Mixed Methods Appraisal Tool. ETHICS AND DISSEMINATION: All data in this project will be gathered through database searches. Stakeholder consultation will be undertaken with an established patient and public involvement group. We will disseminate our findings via social media, publication and engagement meetings. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: rehabilitation medicine; sports medicine
Mesh:
Year: 2022 PMID: 35508347 PMCID: PMC9073409 DOI: 10.1136/bmjopen-2022-061104
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Inclusion and exclusion criteria
| Inclusion criteria | Exclusion criteria |
| Any study design examining interventions or intervention content (eg, single-group preintervention and postintervention, parallel-group, crossover or cluster designs, qualitative studies and process evaluations relating to interventions) | Studies in children or animals |
| Adults aged 18 years and above | Presence of MLTCs not defined or <50% of the sample report MLTCs |
| Living with both frailty and MLTCs | Recognised measure of frailty or validated proxy not used |
| Interventions with a sedentary behaviour, physical activity or exercise focus, including multicomponent interventions | Non-English language studies |
| Any setting | Studies of acute responses to sedentary behaviour, physical activity or exercise, including interventions of <1 week in duration |
MLTC, multiple long-term condition.
Conditions included within the review
| Type 2 diabetes | Asthma |
| COPD | Arthritis (osteo and rheumatoid) |
| Depression | Anxiety |
| Cancer (solid organ, haematological and metastatic) | HIV and AIDS |
| Chronic kidney disease | Chronic liver disease |
| Heart failure | Peripheral artery disease |
| Coronary artery disease | Hyperlipidaemia |
| Obesity | Ischaemic heart disease |
| Osteoporosis | Multiple sclerosis |
| Parkinson’s disease |
AIDS, Acquired immunodeficiency syndrome; COPD, chronic obstructive pulmonary disease; HIV, Human Immunodeficiency virus.
Functional measures which are recognised proxy measures of frailty, and published cut-offs indicative of frailty
| Function test | Published cut points for the identification of frailty |
| Modified physical performance test | Score range: 0–36: Not frail: 32–36 Mild frailty: 25–32 Moderate frailty: 17–24 Dependent: <17 |
| Balance performance oriented mobility assessment (BPOMA) | BPOMA >19 |
| Short physical performance battery | A score of ≤7 is indicative of frailty |
| Timed get-up-and-go test | A score of ≥9 s |
| Gait speed test | A gait speed of 0.8 m/s is indicative of frailty |
| Sit to stand tests: Sit to stand 10 s Sit to stand 30 s Sit to stand 60 s Sit to stand 5 repetitions Sit to stand 10 repetitions | Dependent on the type of sit to stand test used: ≥10 s for the five times sit stand Lower than published criterion standards to maintain independence, stratified by age and gender for other forms of the test |
| Handgrip strength | Scores within the lowest quartile, stratified by sex |
| Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire | Score of ≥4 |
Key data to be extracted within the review
| Study details | Author(s) |
| Type of publication | |
| Year of publication | |
| Country of origin | |
| Description of methodology | Aims/Purpose |
| Study design | |
| Inclusion and exclusion criteria | |
| Definition of frailty and frailty assessment or proxy functional measure used | |
| Primary and secondary outcomes | |
| Where applicable, definition of the carers involved | |
| Setting/Context (geographical, cultural, social environment and the organisational and political systems in which an intervention occurs) | |
| Sample size | |
| Characteristics of the study population, including: Age Sex Indicators of socioeconomic status Presence of cognitive impairment Number, type and severity of long-term conditions Level of frailty of participants | |
| Where applicable, characteristics of carers or family members or significant others, including relationship to care receiver | |
| Description of intervention | Focus of the intervention (sedentary behaviour, physical activity, exercise or combination) |
| If applicable, the type of physical activity/ exercise, including equipment used and an outline of the components included | |
| The methods used to prescribe the intervention | |
| The decision rules for determining the starting level | |
| The intervention duration and dose, that is, the prescribed frequency and intensity, the duration of the intervention and any maintenance period | |
| The mode of delivery (face-to-face, virtual, individual or group) | |
| The decision rules for determining progression | |
| Details of how the programme was progressed and how this was monitored | |
| The location/setting of delivery (eg, home-based or in-centre) including any necessary infrastructure or other relevant features | |
| Details, methods of and reasons for tailoring, personalisation or adaptation. | |
| Details and methods of any modifications to the intervention during the study, particularly in relation to periods of ill-health and fluctuating symptomology | |
| Intervention rationale, programme theory or goals | |
| The physical or informational materials used in the intervention, including those provided to participants or used in intervention delivery or in training of intervention providers | |
| The procedures, activities and/or processes used in the intervention, including any enabling or supportive activities, motivation strategies used (eg, counselling/education; environmental modification; prompting; self-monitoring; social comparison; financial incentives) | |
| Amount of supervision, including contact time | |
| The intervention providers, including their qualifications/expertise, background and any training provided to them | |
| Description of how carers, relatives or significant others are included within the design, development or delivery of the intervention | |
| How intervention fidelity was assessed, and by whom, including methods for measuring adherence will also be included | |
| Strategies used to maintain or improve fidelity | |
| How well the intervention was delivered as planned, including recorded levels of adherence to the programme |